{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:12:43Z","timestamp":1790820763212,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00464-025-11944-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:40:28Z","timestamp":1752140428000},"page":"4752-4764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The efficacy of antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease (GERD) by 24-h pH monitoring: systematic review and meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6465-8076","authenticated-orcid":false,"given":"Hasan","family":"Al-Obaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooraldin","family":"Merza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Wakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Rabeeah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Al-Obaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhareth","family":"Alsagban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Algodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Kobeissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Sharaiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"67","key":"11944_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","volume":"2018","author":"LHRR Eusebi","year":"2018","unstructured":"Eusebi LHRR, Yuan Y (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018(67):430\u2013440","journal-title":"Gut"},{"issue":"8","key":"11944_CR2","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900\u20131920","journal-title":"Am J Gastroenterol"},{"key":"11944_CR3","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/07853890.2022.2074535","volume":"54","author":"DLS Zhang","year":"2022","unstructured":"Zhang DLS, Li Z, Wang R (2022) Global, regional and national burden of gastroesophageal reflux disease, 1990\u20132019: update from the GBD 2019 study. Ann Med 54:1372\u20131384","journal-title":"Ann Med"},{"issue":"59","key":"11944_CR4","first-page":"1161","volume":"1999","author":"MGA Scott","year":"1999","unstructured":"Scott MGA (1999) Gastroesophageal reflux disease: diagnosis and management. Am Fam Physician 1999(59):1161\u20131169","journal-title":"Am Fam Physician"},{"key":"11944_CR5","first-page":"5","volume":"25","author":"PW Boulton Khad","year":"2022","unstructured":"Boulton Khad PW (2022) A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Ann Esophagus 25:5","journal-title":"Ann Esophagus"},{"issue":"35","key":"11944_CR6","first-page":"1257","volume":"2012","author":"JB Tack","year":"2012","unstructured":"Tack JB, Mulligan A, Johnson C (2012) Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment. Pharmacol Ther 2012(35):1257\u20131266","journal-title":"Pharmacol Ther"},{"key":"11944_CR7","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/ajg.2011.146","volume":"106","author":"PJ Kahrilas","year":"2011","unstructured":"Kahrilas PJ (2011) Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol 106:1419\u20131425","journal-title":"Am J Gastroenterol"},{"issue":"30","key":"11944_CR8","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/MEG.0000000000001198","volume":"2018","author":"MPT Islam","year":"2018","unstructured":"Islam MPT, Walther BA (2018) Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018(30):1395\u20131405","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"11944_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","volume":"2004","author":"BBGAJ Dean","year":"2004","unstructured":"Dean BBGAJ, Knight K et al (2004) Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004(2):656\u2013664","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"35","key":"11944_CR10","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1007\/s00464-020-08144-9","volume":"2021","author":"HJSB Wong","year":"2021","unstructured":"Wong HJSB, Attaar M et al (2021) Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication. Surg Endosc 2021(35):7174\u20137182","journal-title":"Surg Endosc"},{"issue":"8","key":"11944_CR11","first-page":"E133","volume":"2020","author":"HTM Inoue","year":"2020","unstructured":"Inoue HTM, de Santiago ER (2020) Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study. Endosc Int Open 2020(8):E133\u2013E138","journal-title":"Endosc Int Open"},{"issue":"27","key":"11944_CR12","first-page":"346","volume":"2014","author":"HIH Inoue","year":"2014","unstructured":"Inoue HIH, Ikeda H et al (2014) Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol 2014(27):346\u2013351","journal-title":"Ann Gastroenterol"},{"issue":"255","key":"11944_CR13","first-page":"2017","volume":"32","author":"AMM Bapaye","year":"2017","unstructured":"Bapaye AMM, Pujari R et al (2017) Anti-reflux mucosectomy (ARMS) for refractory GERD-Initial clinical experience. J Gastroenterol Hepatol 32(255):2017","journal-title":"J Gastroenterol Hepatol"},{"key":"11944_CR14","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.gie.2020.04.046","volume":"92","author":"HM Victor","year":"2020","unstructured":"Victor HM, Garc\u00eda Contreras ZMR (2020) Clinical feasibility of a new anti-reflux ablation therapy on gastroesophageal reflux disease (with video). Gastrointest Endosc 92:1190\u20131201","journal-title":"Gastrointest Endosc"},{"key":"11944_CR15","doi-asserted-by":"crossref","unstructured":"Higgins JPT TJ, Chandler J, Cumpston M, Li T (2019) Cochrane handbook for systematic reviews of interventions. Page MJ, Welch VA (editors) 2nd Edition John Wiley & Sons, Chichester","DOI":"10.1002\/9781119536604"},{"key":"11944_CR16","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2022.112","author":"MJ Page","year":"2022","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, Moher D (2022) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Panamericana de Salud Publica\/Pan Am J Public Health. https:\/\/doi.org\/10.26633\/RPSP.2022.112","journal-title":"Rev Panamericana de Salud Publica\/Pan Am J Public Health"},{"key":"11944_CR17","first-page":"205","volume-title":"Jones DR methods for meta-analysis in medical research","author":"AJAK Sutton","year":"2000","unstructured":"Sutton AJAK (2000) Jones DR methods for meta-analysis in medical research. John Wiley & Sons Ltd, New York, pp 205\u2013228"},{"issue":"25","key":"11944_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"2010","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non-randomized studies in meta-analyses. Europ J Epidemiol 2010(25):603\u2013605","journal-title":"Europ J Epidemiol"},{"key":"11944_CR19","doi-asserted-by":"crossref","unstructured":"Debourdeau A VV, Monino L, Barthet M, Gonzalez JM (2020) Anti-reflux mucosectomy band (ARM-b) in treatment of refractory gastroesophageal reflux disease after bariatric surgery. Obes Surg 30(11):4654\u20134658 101007\/s11695\u2013020\u201304753\u20134 Epub 2020 Jul 16 PMID: 32676843","DOI":"10.1007\/s11695-020-04753-4"},{"key":"11944_CR20","doi-asserted-by":"crossref","unstructured":"Klimczak T, Strzelczyk J (2023) Endoscopic anti-reflux mucosectomy (ARMS) and endoscopic anti-reflux ablation (ARMA) as a potential treatment for gastroesophageal reflux \u2013 preliminary report. Polish J Surg 96(Suppl 1):1\u20135","DOI":"10.5604\/01.3001.0053.9251"},{"key":"11944_CR21","doi-asserted-by":"crossref","unstructured":"Laqui\u00e8re A T-TF, Urena-Campos R, Lienne P, Lecomte L, Katsogiannou M, Penaranda G, Bousti\u00e8re C (2022) Evaluation of antireflux mucosectomy for severe gastroesophageal reflux disease: medium-term results of a pilot study. Gastroenterol Res Pract 2022:1606944","DOI":"10.1155\/2022\/1606944"},{"key":"11944_CR22","doi-asserted-by":"crossref","unstructured":"Patil G DA, Maydeo A (2020) Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video). Dig Endosc 32(5):745\u2013752","DOI":"10.1111\/den.13606"},{"key":"11944_CR23","doi-asserted-by":"crossref","unstructured":"Shimamura Y IH, Tanabe M, Ushikubo K, Yamamoto K, Kimoto Y, Nishikawa Y, Ando R, Sumi K, Navarro MJ, Teruel Sanchez-Vegazo C, Pe\u00f1as B, Parejo S, Mart\u00ednez S\u00e1nchez A, Vazquez-Sequeiros E, Onimaru M, Albillos A, Rodriguez de Santiago E (2024) Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study. J Gastroenterol Hepatol 39(1):149\u2013156","DOI":"10.1111\/jgh.16370"},{"key":"11944_CR24","doi-asserted-by":"crossref","unstructured":"Sumi K IH, Kobayashi Y, Iwaya Y, Abad MRA, Fujiyoshi Y, Shimamura Y, Ikeda H, Onimaru M (2021) Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases. Dig Endosc 33(3):347\u2013354","DOI":"10.1111\/den.13727"},{"key":"11944_CR25","doi-asserted-by":"crossref","unstructured":"Yang X TJ, Liu Y, Feng Y, Shi R (2022) Comparison of 180\u00b0 anti-reflux mucosectomy versus 270\u00b0 anti-reflux mucosectomy for treatment of refractory gastroesophageal reflux disease: a retrospective study. Surg Endosc 36(7):5002\u20135010","DOI":"10.1007\/s00464-021-08857-5"},{"key":"11944_CR26","doi-asserted-by":"crossref","unstructured":"Yoo IK KW, Kim HS, Kim HK, Kim JH, Kim WH, Hong SP, Yeniova A\u00d6, Cho JY (2020) Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study. Surg Endosc 34(3):1124\u20131131","DOI":"10.1007\/s00464-019-06859-y"},{"key":"11944_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3286738","author":"XZW Li","year":"2019","unstructured":"Li XZW, Chen M et al (2019) A prospective randomized trial to assess the anti-reflux effect of anti-reflux mucosectomy in the porcine model. Gastroenterol Res Pract. https:\/\/doi.org\/10.1155\/2019\/3286738","journal-title":"Gastroenterol Res Pract"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-11944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-11944-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-11944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T03:20:01Z","timestamp":1757215201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-11944-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["11944"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-11944-6","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Reem Z. Sharaiha:\u00a0has received payment or honoraria for lectures, presentations, speakers\u2019 bureaus, manuscript writing, or educational events from Boston Scientific, Olympus, Cook, and Surgical Intuitive. Dr. Hasan Al-Obaidi\u00a0has no conflicts of interest or financial ties to disclose. Dr. Omar Saab\u00a0has no conflicts of interest or financial ties to disclose. Dr. Nooraldin Merza\u00a0has no conflicts of interest or financial ties to disclose. Dr. Ali Wakil\u00a0has no conflicts of interest or financial ties to disclose. Dr. Sana Rabeeah\u00a0has no conflicts of interest or financial ties to disclose. Dr. Mustafa Al-Obaidi\u00a0has no conflicts of interest or financial ties to disclose. Dr. Alhareth Alsagban\u00a0has no conflicts of interest or financial ties to disclose. Dr. Marwah Algodi\u00a0has no conflicts of interest or financial ties to disclose. Dr. Muhammad Usman Baig\u00a0has no conflicts of interest or financial ties to disclose. Dr. Abdallah Kobeissy\u00a0has no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}